Download FREE Report Sample
Download Free sampleTuberculosis is a chronic wasting infectious disease caused by Mycobacterium tuberculosis. The drugs used to treat this disease are anti-tuberculosis drugs.
Anti-Tuberculosis Drug Market contains market size and forecasts of Anti-Tuberculosis Drug in global, including the following market information:
Global Anti-Tuberculosis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-Tuberculosis Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-Tuberculosis Drug companies in 2021 (%)
The global Anti-Tuberculosis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
First-Line Anti-Tuberculosis Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Tuberculosis Drug include Lupin, Otsuka, Sanofi, Prizer, Abbott and NOVARTIS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Tuberculosis Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Tuberculosis Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Tuberculosis Drug Market Segment Percentages, by Type, 2021 (%)
First-Line Anti-Tuberculosis Drugs
Second-Line Anti-Tuberculosis Drugs
Global Anti-Tuberculosis Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Tuberculosis Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Anti-Tuberculosis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Tuberculosis Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Tuberculosis Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-Tuberculosis Drug revenues share in global market, 2021 (%)
Key companies Anti-Tuberculosis Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anti-Tuberculosis Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lupin
Otsuka
Sanofi
Prizer
Abbott
NOVARTIS
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
